FDA Weighs Fate of Qnexa for Weight Loss, Again (HealthDay)
HealthDay – TUESDAY, Feb. 21 (HealthDay News) — The U.S. Food and Drug
Administration plans to take a second look at the weight loss pill Qnexa
on Wednesday, after initially rejecting it because of concerns about heart
problems and possible birth defects.